JIANGSU YAHONG MEDITECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.37 CNY | +3.67% |
|
-0.56% | -50.19% |
| 06-25 | Yahong Meditech to Trial Drug Against Amoebae Infection | MT |
| 06-17 | ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 421M | - | - | - | |||
| 122B | ||||||
| 115B | ||||||
| 26.64B | - | |||||
| 19.91B | - | |||||
| 16.32B |
